Join the Duke Center for Quantitative Biodesign on Friday, November 8, 2024 from 3-4:00 pm in Wilkinson 021 as we hear from our next guest speaker, Dr. Theresa M. Reineke.
Dr. Reineke is the Prager Endowed Chair in Macromolecular Science and a Distinguished McKnight University Professor in the Department of Chemistry at the University of Minnesota. She also holds graduate faculty appointments in the Departments of Chemical Engineering/Materials Science and Pharmaceutics. She received a B.S. Degree from the University of Wisconsin-Eau Claire, a M.S. Degree from Arizona State University, and a Ph.D. from the University of Michigan. She then received a National Institutes of Health Postdoctoral Research Fellowship for her work in gene therapy at the California Institute of Technology prior to beginning her independent faculty career.
Her research group is focused on enabling fundamental and applied technology advancements in the fields of macromolecules for nucleic acid delivery and gene editing, oral delivery of therapeutics, and sustainability. She has published over 200 peer-reviewed manuscripts and patents and manages a large group of researchers supported by several corporate, private and national funding agencies. Reineke is a Fellow of the American Chemical Society, Royal Society of Chemistry, along with the Kavli and Alfred P. Sloan Foundations. She has received numerous awards, including in the 2005 National Science Foundation CAREER and Beckman Foundation Young Investigator Awards, 2008 Camille and Henry Dreyfus Teacher-Scholar Award, 2009 National Institutes of Health Director’s New Innovator Award, 2012 Outstanding New Investigator Award from the American Society of Gene and Cell Therapy, 2017 Carl S. Marvel Creative Polymer Chemistry Award from the American Chemical Society Division of Polymer Chemistry, 2018 DuPont Nutrition and Health Sciences Excellence Medal, and 2022 Arthur C. Cope Scholar Award from the American Chemical Society. Reineke has also served for 11 years as an Associate Editor for the journals ACS MacroLetters and Chemical Science and in 2023 became Editor-in Chief of Bioconjugate Chemistry. Further, Reineke has cofounded three biotech companies in the field of nucleic acid delivery: Techulon, Inc., Nanite, Inc., and LiberateBio, Inc.
